Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms

MD LaFleur, E Lucumi, AD Napper… - Journal of …, 2011 - academic.oup.com
Objectives Microbial adhesion and biofilms have important implications for human health
and disease. Candida albicans is an opportunistic pathogen which forms drug-resistant …

High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors

SA Siles, A Srinivasan, CG Pierce… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Candida albicans is the most common etiologic agent of systemic fungal infections with
unacceptably high mortality rates. The existing arsenal of antifungal drugs is very limited and …

Screening the Pathogen Box for identification of Candida albicans biofilm inhibitors

T Vila, JL Lopez-Ribot - Antimicrobial Agents and Chemotherapy, 2017 - Am Soc Microbiol
Candida albicans remains the main causative agent of candidiasis, one of the most frequent
nosocomial infections, with unacceptably high mortality rates. Biofilm formation is a major …

[HTML][HTML] A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance

CG Pierce, AK Chaturvedi, AL Lazzell… - npj Biofilms and …, 2015 - nature.com
Methods: To address the pressing need for new antifungals, we have performed a high-
content screen of 20,000 small molecules in a chemical library (NOVACore) to identify …

[HTML][HTML] A Selective Serotonin Reuptake Inhibitor, a Proton Pump Inhibitor, and Two Calcium Channel Blockers Inhibit Candida albicans Biofilms

CJ Nobile, CL Ennis, N Hartooni, AD Johnson… - Microorganisms, 2020 - mdpi.com
Biofilms formed by the human fungal pathogen Candida albicans are naturally resistant to
many of the antifungal agents commonly used in the clinic. We screened a library containing …

[HTML][HTML] Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms

T Watamoto, H Egusa, T Sawase, H Yatani - Frontiers in Microbiology, 2015 - frontiersin.org
Candida species have emerged as important and common opportunistic human pathogens,
particularly in immunocompromised individuals. The current antifungal therapies either have …

Combinatorial drug approaches to tackle Candida albicans biofilms

K De Cremer, I Staes, N Delattin… - Expert Review of Anti …, 2015 - Taylor & Francis
The human fungal opportunistic pathogen Candida albicans resides in the human gut,
genitourinary tract and on the skin. The majority of infections caused by C. albicans are …

Techniques for Antifungal Susceptibility Testing of Candida albicans Biofilms

G Ramage, JL López-Rib - Antifungal Agents: Methods and Protocols, 2005 - Springer
Candida albicans is capable of forming biofilms on a variety of inert and biological surfaces.
Cells in biofilms display phenotypic properties that are radically different from their free …

High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation

CG Pierce, SP Saville, JL Lopez-Ribot - Pathogens and disease, 2014 - academic.oup.com
Candida species represent the main cause of opportunistic fungal infections worldwide, and
Candida albicans remains the most common etiological agent of candidiasis, now the third …

Candida albicans biofilms: antifungal resistance, immune evasion, and emerging therapeutic strategies

FM Fan, Y Liu, YQ Liu, RX Lv, W Sun, WJ Ding… - International Journal of …, 2022 - Elsevier
Candida albicans is a fungal pathogen that can form biofilms on medical devices and host
tissue, resulting in serious, life-threatening infections. These fungal biofilms are inherently …